Literature DB >> 22987149

Hypoxia and gerosuppression: the mTOR saga continues.

Olga V Leontieva1, Mikhail V Blagosklonny.   

Abstract

Growth-promoting and nutrient/mitogen-sensing pathways such as mTOR convert p21- and p16-induced arrest into senescence (geroconversion). We have recently demonstrated that hypoxia, especially near-anoxia, suppresses geroconversion. This gerosuppressive effect of hypoxia correlated with inhibition of the mTOR/S6K pathway but not with modulation of the LKB1/AMPK/eEF2 pathway. Here we further show that mTOR inhibition is required for gerosuppression by hypoxia, at least in some cellular models, because depletion of TSC2 abolished mTOR inhibition and gerosupression by hypoxia. Also, in two cancer cell lines resistant to inhibition of mTOR by both p53 and hypoxia, hypoxia did not suppress geroconversion. Therefore, the effects of hypoxia on the oxygen-sensing mTOR pathway and geroconversion are cell type-specific. We also briefly discuss replicative senescence, organismal aging and free radical theory.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22987149      PMCID: PMC3507487          DOI: 10.4161/cc.21908

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  65 in total

1.  A new path to longevity.

Authors:  David Stipp
Journal:  Sci Am       Date:  2012-01       Impact factor: 2.142

2.  Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.

Authors:  Marina Kolesnichenko; Lixin Hong; Rong Liao; Peter K Vogt; Peiqing Sun
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

3.  Augmented autophagy pathways and MTOR modulation in fibroblasts from long-lived mutant mice.

Authors:  Min Wang; Richard A Miller
Journal:  Autophagy       Date:  2012-06-01       Impact factor: 16.016

Review 4.  Prospective treatment of age-related diseases by slowing down aging.

Authors:  Mikhail V Blagosklonny
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

5.  Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice.

Authors:  Vladimir N Anisimov; Mark A Zabezhinski; Irina G Popovich; Tatiana S Piskunova; Anna V Semenchenko; Margarita L Tyndyk; Maria N Yurova; Svetlana V Rosenfeld; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

6.  Suppression of replicative senescence by rapamycin in rodent embryonic cells.

Authors:  Tatiana V Pospelova; Olga V Leontieva; Tatiana V Bykova; Svetlana G Zubova; Valery A Pospelov; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

7.  Hypoxia suppresses conversion from proliferative arrest to cellular senescence.

Authors:  Olga V Leontieva; Venkatesh Natarajan; Zoya N Demidenko; Lyudmila G Burdelya; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

8.  Rapamycin slows aging in mice.

Authors:  John E Wilkinson; Lisa Burmeister; Susan V Brooks; Chi-Chao Chan; Sabrina Friedline; David E Harrison; James F Hejtmancik; Nancy Nadon; Randy Strong; Lauren K Wood; Maria A Woodward; Richard A Miller
Journal:  Aging Cell       Date:  2012-06-04       Impact factor: 9.304

9.  Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2012-03       Impact factor: 5.682

10.  Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production.

Authors:  Claudia Capparelli; Carmela Guido; Diana Whitaker-Menezes; Gloria Bonuccelli; Renee Balliet; Timothy G Pestell; Allison F Goldberg; Richard G Pestell; Anthony Howell; Sharon Sneddon; Ruth Birbe; Aristotelis Tsirigos; Ubaldo Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

View more
  20 in total

Review 1.  Stem cells, redox signaling, and stem cell aging.

Authors:  Raymond Liang; Saghi Ghaffari
Journal:  Antioxid Redox Signal       Date:  2014-01-02       Impact factor: 8.401

2.  MEK drives cyclin D1 hyperelevation during geroconversion.

Authors:  O V Leontieva; Z N Demidenko; M V Blagosklonny
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

3.  Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.

Authors:  Karin Hoppe-Seyler; Felicitas Bossler; Claudia Lohrey; Julia Bulkescher; Frank Rösl; Lars Jansen; Arnulf Mayer; Peter Vaupel; Matthias Dürst; Felix Hoppe-Seyler
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

4.  Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.

Authors:  Javier A Menendez; Tomás Alarcón; Jorge Joven
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 4.534

5.  HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.

Authors:  Clémence Coudre; Julien Alani; William Ritchie; Véronique Marsaud; Brigitte Sola; Julie Cahu
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

6.  Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.

Authors:  Javier A Menendez; Jorge Joven; Gerard Aragonès; Enrique Barrajón-Catalán; Raúl Beltrán-Debón; Isabel Borrás-Linares; Jordi Camps; Bruna Corominas-Faja; Sílvia Cufí; Salvador Fernández-Arroyo; Anabel Garcia-Heredia; Anna Hernández-Aguilera; María Herranz-López; Cecilia Jiménez-Sánchez; Eugeni López-Bonet; Jesús Lozano-Sánchez; Fedra Luciano-Mateo; Begoña Martin-Castillo; Vicente Martin-Paredero; Almudena Pérez-Sánchez; Cristina Oliveras-Ferraros; Marta Riera-Borrull; Esther Rodríguez-Gallego; Rosa Quirantes-Piné; Anna Rull; Laura Tomás-Menor; Alejandro Vazquez-Martin; Carlos Alonso-Villaverde; Vicente Micol; Antonio Segura-Carretero
Journal:  Cell Cycle       Date:  2013-01-31       Impact factor: 4.534

7.  Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.

Authors:  Olga V Leontieva; Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

8.  Functional properties of bone marrow derived multipotent mesenchymal stromal cells are altered in heart failure patients, and could be corrected by adjustment of expansion strategies.

Authors:  Renata I Dmitrieva; Alla V Revittser; Maria A Klukina; Yuri V Sviryaev; Ludmila S Korostovtseva; Anna A Kostareva; Andrey Yu Zaritskey; Evgeny V Shlyakhto
Journal:  Aging (Albany NY)       Date:  2015-01       Impact factor: 5.682

9.  Molecular dynamics of the full-length p53 monomer.

Authors:  Giovanni Chillemi; Pavel Davidovich; Marco D'Abramo; Tazhir Mametnabiev; Alexander Vasilievich Garabadzhiu; Alessandro Desideri; Gerry Melino
Journal:  Cell Cycle       Date:  2013-09-05       Impact factor: 4.534

10.  Running m(o)TOR with the brakes on leads to catastrophe at mitosis.

Authors:  Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2012-12-06       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.